<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2017.53014</article-id><article-id pub-id-type="publisher-id">JBM-74902</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Inhibition of the Na&lt;sup&gt;+&lt;/sup&gt;/Ca&lt;sup&gt;2+&lt;/sup&gt; Exchanger NCX&lt;sub&gt;1&lt;/sub&gt; Expressed in &lt;i&gt;Xenopus&lt;/i&gt; Oocyte by Glycyrrhizic Acid and Cyclophylin A
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jan</surname><given-names>Laudenbach</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Beibei</surname><given-names>Xing</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Silvia</surname><given-names>Schwarz</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yinfang</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Quanbao</surname><given-names>Gu</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wolfgang</surname><given-names>Schwarz</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Max-Planck-Institute for Biophysics and Institute for Biophysics, Frankfurt am Main, Germany</addr-line></aff><aff id="aff2"><addr-line>Shanghai Research Institute of Acupuncture &amp;amp; Moxibustion and Meridian, Shanghai, China</addr-line></aff><aff id="aff5"><addr-line>Institute for Biophysics, Goethe University, Frankfurt am Main, Germany</addr-line></aff><aff id="aff4"><addr-line>Shanghai Research Center for Acupuncture &amp;amp; Meridians, Shanghai, China</addr-line></aff><aff id="aff3"><addr-line>Shanghai Key Laboratory for Acupuncture Mechanism and Acupoint Function, Shanghai, China</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>03</month><year>2017</year></pub-date><volume>05</volume><issue>03</issue><fpage>128</fpage><lpage>141</lpage><history><date date-type="received"><day>November</day>	<month>23,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>March</month>	<year>24,</year>	</date><date date-type="accepted"><day>March</day>	<month>27,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The Na
  <sup>+</sup>/Ca
  <sup>2+</sup> exchanger plays an important role in regulation of airway smooth muscle contraction by regulating intracellular calcium, and is a potential target for treatment of asthma. To test modulation of exchanger activity, we used 
  <em>Xenopus</em> oocytes as model system. Na
  <sup>+</sup>/Ca
  <sup>2+</sup> exchanger was expressed in the cells by microinjection of cRNA of the exchanger isoform NCX
  <sub>1</sub>. The activity of NCX
  <sub>1</sub> was determined as Ni
  <sup>2+</sup>-sensitive current under voltage clamp in low Cl
  <sup>–</sup> medium and in the presence of the Cl
  <sup>–</sup>-channel inhibitor niflumic acid. Only this composition of solution allowed determining NCX
  <sub>1</sub>-mediated current with sufficient accuracy. Among a few tested Chinese herbal drugs, glycyrrhizic acid turned out to be a potent inhibitor of NCX
  <sub>1</sub> with an apparent IC
  <sub>50</sub> value of 40 μM. Previous work had revealed elevated cyclophylin A concentration in serum of asthmatic rats after receiving acupuncture treatment. Extracellular incubation of the oocytes in cyclophylin A for one day led to significant inhibition with an apparent IC
  <sub>50</sub> value of about 1 μM. We suggest that effects of acupuncture and application of glycyrrhizic acid as an active constituent of Chinese medicine for treatment of asthma symptoms may partially be attributed to inhibition of the reversed mode of NCX
  <sub>1</sub> and that these compounds may stimulate the search for new anti-asthmatic drugs.
 
</p></abstract><kwd-group><kwd>Sodium-Calcium Exchanger</kwd><kwd> Asthma</kwd><kwd> Voltage Clamp</kwd><kwd> Glycyrrhizic  Acid</kwd><kwd> Cyclophylin A</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Asthma is a disease characterised by reversible contraction of airway smooth muscle (ASM). Several signalling pathways are now known to be related to the process of ASM contraction, and almost all of them involve Ca<sup>2+</sup> handling [<xref ref-type="bibr" rid="scirp.74902-ref1">1</xref>] . Cytoplasmic Ca<sup>2+</sup> activity (<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/10-2150320x2.png" xlink:type="simple"/></inline-formula>) homeostasis is controlled by several ionic signalling mechanisms, one of which is the reversed mode of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX) of the plasma membrane [<xref ref-type="bibr" rid="scirp.74902-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref3">3</xref>] . Although little is currently known about NCX in the airways and its involvement in asthma, some investigators have shown that expression and function of the isoform 1 of the exchanger (named NCX<sub>1</sub>) in ASM is up-regulated in asthmatic animals and inhibition of NCX may ameliorate the symptoms of asthma. This observation makes NCX a potential target for asthma treatment [<xref ref-type="bibr" rid="scirp.74902-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref4">4</xref>] . The aim of the present study was to examine effects of various chemicals that might act as inhibitors of NCX.</p><p>In traditional medicine, herbal extracts are often applied in treatment of asthma, and the search for natural components has become promising to discover new anti-asthmatic drugs. Extracts of roots of licorice (Glycyrrhiza glabra) have been applied in treatment of a large variety of diseases (see e.g. [<xref ref-type="bibr" rid="scirp.74902-ref5">5</xref>] ). The triterpene glycoside glycyrrhizic acid (GA) is one of the major active constituents of licorice:</p><disp-formula id="scirp.74902-formula3"><graphic  xlink:href="http://html.scirp.org/file/10-2150320x3.png"  xlink:type="simple"/></disp-formula><p>GA has been used as a hepatoprotective drug [<xref ref-type="bibr" rid="scirp.74902-ref5">5</xref>] , and recent studies also revealed its anti-asthmatic effects [<xref ref-type="bibr" rid="scirp.74902-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref7">7</xref>] . Though modulation of various pathways has been discussed (see [<xref ref-type="bibr" rid="scirp.74902-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref9">9</xref>] ), it is unclear whether GA can interfere with NCX<sub>1</sub>, and hence exert its anti-asthmatic effects.</p><p>In a recent investigation on rats, we found significantly elevated cyclophilin A (CyPA) level in the serum of acupuncture-treated asthmatic rats compare to that of untreated rats [<xref ref-type="bibr" rid="scirp.74902-ref10">10</xref>] . CyPA is a member of the cyclophilin (CyP) family, which possesses peptidyl-prolyl isomerase (PPIase) activity. CyPs are involved in diverse cellular processes including cell-cycle regulation, receptor signalling, protein folding, and they form cellular targets for immune-suppressant drugs such as cyclosporine A (CsA) [<xref ref-type="bibr" rid="scirp.74902-ref11">11</xref>] . CyPA has multiple intracellular functions (see e.g. [<xref ref-type="bibr" rid="scirp.74902-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref13">13</xref>] ), but can also be secreted [<xref ref-type="bibr" rid="scirp.74902-ref14">14</xref>] and act extracellularly as an inflammatory mediator that may be involved in inflammatory diseases such as atherosclerosis [<xref ref-type="bibr" rid="scirp.74902-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref16">16</xref>] and rheumatoid arthritis [<xref ref-type="bibr" rid="scirp.74902-ref17">17</xref>] . In our investigation we consider extracellular CyPA as a drug for treatment of asthma by inhibiting NCX, which might be a molecular mechanism of asthma therapy by acupuncture. In this study, we choose the human cyclophilin A (hCyPA), one of 7 major cyclophilins in humans [<xref ref-type="bibr" rid="scirp.74902-ref18">18</xref>] .</p><p>To monitor changes of transport activity of the exchanger, we used the Xeno- pus oocyte for heterologous expression of NCX<sub>1</sub>. NCX operates at a 3:1 or 4:1 Na<sup>+</sup>:Ca<sup>2+</sup> stoichiometry [<xref ref-type="bibr" rid="scirp.74902-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref20">20</xref>] , the transporter is electrogenic, therefore, the activities can be monitored by measuring current using two-electrode voltage clamp (TEVC). Since the oocytes have functionally expressed only a limited number of endogenous membrane proteins, the application of this model system allows investigating effects on NCX with low background signals and restricted functional interference from other membrane proteins.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. NCX<sub>1</sub>-cRNA and hCyPA Preparation</title><p>The construct with NCX<sub>1</sub> of dog was kindly provided by Dr. Luis Beauge (Laboratorio de Biophisica, Cordoba, Argentina) and linearised with XbaI, then transcribed into cRNA in vitro using mMESSAGEmMACHINESP6 kit (Ambion, USA). The final concentration of cRNA was adjusted to 0.2 ng/nL.</p><p>The plasmid pQE30-CyPA was kindly provided by Dr. Xu Sheng (Drug Discovery and Design Center and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences). Expression and purification of the hCyPA protein was performed as described elsewhere [<xref ref-type="bibr" rid="scirp.74902-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref22">22</xref>] . Gels and buffers used for native PAGE were made according to the standard Laemmli SDS protocol omitting the SDS. Native gels (12% polyacrylamide) were run at 12 mA and 45 min and stained with Coomassie Brilliant Blue R-250. The molecular weight of hCyPA was slightly less than 20 kDa (compare <xref ref-type="fig" rid="fig1">Figure 1</xref>) in line with the reported weight of 18 kDa. Unstained protein-molecular-weight marker was from Fermentas Life Science (USA).</p></sec><sec id="s2_2"><title>2.2. Xenopus Oocytes Preparation and Microinjection</title><p>Xenopus oocytes were used as expression for NCX<sub>1</sub> and as a model system to test the effects of herbal extracts and CyPA. This expression system is particularly suited because endogenous ion channels and transporters are functionally expressed only to a low extend, and hence, exogenous current components can easily be extracted. Females of the clawed toad Xenopus laevis (purchased from Maosheng Bio-Technology Com., Shanghai, China) were anaesthetised in a bath medium containing 1 g/L tricaine (Sandoz, Basel, Switzerland) and kept on ice. Parts of ovary were removed and treated with 0.5 or 0.25 mg/mL collagenase (Sigma) for 2 - 4 h, or overnight, respectively. Full-grown prophase-arrested</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> SDS-PAGE analysis of hCyPA. Lane 1: hCyPA- antibody marked band at slightly less than 20 kDa. Lane 2: marker</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/10-2150320x4.png"/></fig><p>oocytes of Dumont stages V and VI [<xref ref-type="bibr" rid="scirp.74902-ref23">23</xref>] were selected for cRNA injection, and cultured with daily changed G-ORi solution or C-ORi solution (ORi plus 0.07 μg/mL gentamycin (Sigma) or ciprofloxacin hydrochloride (Sigma), respectively) at 20˚C. For expression of NCX<sub>1</sub> about 1.5 ng NCX<sub>1</sub>-cRNA was microinjected into an ooctye at a flow-rate of 8 nL/s. Uninjected oocytes served as controls.</p><p>For investigating the effect of intracellular hCyPA, oocytes were first microinjected with NCX<sub>1</sub>-cRNA and divided into 4 groups. The cells of each group were additionally microinjected with hCyPA (5, 10, 20 or 40 nl per oocytes, respectively, at a concentration of 4.27 &#181;g/&#181;L). For investigating extracellular effect of hCyPA, oocytes were first microinjected with NCX<sub>1</sub>-cRNA and divided into 4 groups. The cells of each group were then incubated with different amounts of hCyPA; 200 &#181;L of incubation medium contained 1, 2, 4 or 8 &#181;L of hCyPA, respectively (4.27 &#181;g/&#181;L). Thereafter, oocytes were cultured in G-ORi or C-ORi at 20˚C for up to 2 days.</p></sec><sec id="s2_3"><title>2.3. Electrophysiological Recording</title><p>Since NCX is electrogenic, NCX-mediated current is a measure for transporter activities. To investigate the function of NCX<sub>1</sub>, membrane currents were measured by conventional two-electrode voltage clamp (TEVC) using Turbo TEC-03 with Cell Works software (NPI electronic, Tamm, Germany). Glass microelectrodes were filled with 3 M KCl, and balanced in ORi solution for at least 30 min before recording. Before measurements, oocytes were loaded with Na<sup>+</sup> by incubating the cells in Na<sup>+</sup>-loading solution for 30 min [<xref ref-type="bibr" rid="scirp.74902-ref24">24</xref>] . Thereafter, cells were kept for at least 30 min in post-loading solution (see solutions). Steady-state current-voltage dependencies were determined by averaging membrane currents during the last 20 ms of 200-ms rectangular voltage pulses from −150 to +30 mV in 10 mV increments that were applied from a holding potential of −60 mV. NCX-dependent current was determined as the difference of total membrane current in the absence and presence of 2 mM NiCl<sub>2</sub> as a specific inhibitor of NCX. The data were collected after analogue filtering at 300 kHz and analysed by Origin software (OriginLab Corp., USA). All experiments were performed at room temperature (about 25˚C).</p></sec><sec id="s2_4"><title>2.4. Solutions and Drugs</title><p>The composition of ORi was (in mM): 90 NaCl, 2 KCl, 2 CaCl<sub>2</sub> and 5 MOPS (adjusted to pH 7.4 with Tris). To elevate intracellular Na<sup>+</sup>, cells were incubated for 30 min in “Na-loading solution” consisting of (in mM): 110 NaCl, 2.5 Na- citrate, 5 MOPS (adjusted to pH 7.4 with Tris) and stored thereafter for at least another 30 min in “Post-loading solution” consisting of (in mM): 100 NaCl, 5 BaCl<sub>2</sub>, 20 TEA, 5 MOPS (adjusted to pH 7.4 with Tris). Standard test solutions contained (in mM): 100 Na-gluconate, 2 CaCl<sub>2</sub>, 0.1 niflumic acid, 5 MOPS, and 0 or 2 mM NiCl<sub>2</sub> (adjusted to pH 7.4 with Tris).</p><p>Herbal extracts were kindly provided from Shanghai Institute Materia Medica (CAS) by Drs. CG Huang and CH Ma (supercritical fluid extraction of root of Acorus tatainowii Schott) and by Dr. LJ Xuan (dried ethanol extracts of Ilex pubescence and Gossampinus malabarica), and were dissolved in DMSO. Final concentration of the herbal extracts in test solution was 40 mg/L.</p><p>GA (CAS 1405-86-3, purity ≥95%) and α-asarone (CAS 2883-98-9, purity 98%) were purchased from SIGMA. Stock solutions of 1 or 100 mM were prepared in DMSO and diluted to the final concentration in the test solution. DMSO concentrations in all test solutions were below 1%, which was without effect on the membrane currents.</p></sec><sec id="s2_5"><title>2.5. Data Analysis</title><p>Analysed data were represented as means (&#177;SEM) from N experiments. Means were considered as significantly different by Student’s t test on the basis of p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The Na<sup>+</sup>/Ca<sup>2+</sup> exchanger is considered to transport 3 or 4 Na<sup>+</sup> against 1 Ca<sup>2+</sup>, and hence generating in its forward mode (Ca<sup>2+</sup> extrusion) an inward-directed current, and in its reversed mode (Ca<sup>2+</sup> uptake) an outward-directed current (for a review see [<xref ref-type="bibr" rid="scirp.74902-ref25">25</xref>] ). To determine this current, we used 2 mM Ni<sup>2+</sup> as an inhibitor of NCX-dependent current. Total membrane current was measured under voltage clamp, and the difference of steady-state current in the absence and presence of Ni<sup>2+</sup> was taken as a measure for NCX-dependent current.</p><sec id="s3_1"><title>3.1. Ni<sup>2+</sup>-Sensitive Currents Represent only in Part NCX<sub>1</sub>-Mediated Current</title><p>In control oocytes not injected with cRNA of NCX<sub>1</sub> Ni<sup>2+</sup>-sensitive could never be detected (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a)), confirming that the cells do not express significant endogenous Na<sup>+</sup>/Ca<sup>2+</sup> exchanger on the plasma membrane [<xref ref-type="bibr" rid="scirp.74902-ref26">26</xref>] . On the contrary,</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Ni<sup>2+</sup>-sensitive current in un-injected and NCX<sub>1</sub>- cRNA-injected oocytes. (a) Only injected oocytes show Ni<sup>2+</sup>- sensitive current. (b) Addition of 100 nM niflumic acid strongly blocked the outward-directed current component, while inward current became enhanced. (c) Reduction of external Cl<sup>−</sup> from 100 to 6 mM strongly blocked the outward-directed com- ponent. The data represent averages of N = 5 to 7 oocytes (&#177;SEM)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/10-2150320x5.png"/></fig><p>oocytes being injected with cRNA of NCX<sub>1</sub> exhibited huge currents, in particular at positive potentials in outward direction. Interestingly, the NCX-dependent current could even exceed 10 &#181;A, which can hardly be mediated by a carrier protein even at high density in the cell membrane. Nevertheless, such large currents had been considered to be mediated by NCX (see e.g. [<xref ref-type="bibr" rid="scirp.74902-ref27">27</xref>] ). On the other hand, Xenopus oocytes exhibit Ca<sup>2+</sup>-activated Cl<sup>−</sup> current (see [<xref ref-type="bibr" rid="scirp.74902-ref28">28</xref>] ). Therefore, an alternative interpretation would be that the transporter operates at these potentials in reversed mode accumulating Ca<sup>2+</sup> at the intracellular membrane surface. This accumulated Ca<sup>2+</sup> would activate the Cl<sup>−</sup> channels. After blocking NCX<sub>1</sub> by Ni<sup>2+</sup> also the Cl<sup>−</sup> channels will no longer be activated.</p><p>To reduce this Ca<sup>2+</sup>-dependent background current, we used as an inhibitor of the Cl<sup>−</sup> channels 100 nM niflumic acid [<xref ref-type="bibr" rid="scirp.74902-ref29">29</xref>] in the test solutions, which indeed led to a considerable reduction of the Ni<sup>2+</sup>-sensitive outward-directed current (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b)); in addition the inward-directed current was enhanced. <xref ref-type="fig" rid="fig2">Figure 2</xref>(c) illustrates that reduction of external Cl<sup>−</sup> from 100 mM to 6 mM , also led to strong inhibition of the outward-directed current. Therefore, in most experiments, if not state otherwise, we used niflumic acid and the Cl<sup>−</sup>-reduced test solution as given in the Materials &amp; Methods Section. The still remaining Ni<sup>2+</sup>- sensitive current in this standard test solution was considered to be mediated by NCX<sub>1</sub>. In the following we will differentiate between “NCX<sub>1</sub>-dependent” (or total Ni<sup>2+</sup>-sensitive) and “NCX<sub>1</sub>-mediated” current.</p></sec><sec id="s3_2"><title>3.2. Drug Effects on NCX<sub>1</sub>-Dependent Current</title><p>For a first rough screening we looked for drug effects on total Ni<sup>2+</sup>-sensitive current. To determine this current, we used standard external oocyte-Ringer’s-like solution (ORi) in the absence of niflumic acid without and with 2 mM NiCl<sub>2</sub>. The extracts of Ilex and Gossampinus showed slight, but statistically significant inhibition at 40 mg/L by about 15% or 25%, respectively; the Acorus extract showed slight stimulation by about 15% of the Ni<sup>2+</sup>-sensitive outwardly directed current at +10 mV (<xref ref-type="table" rid="table1">Table 1</xref>). We also tested several pure compounds in addition to the Acorus extract α-asarone, which showed slight inhibition by 10% (<xref ref-type="table" rid="table1">Table 1</xref>). Out of several tested drugs only the GA from Glycyrrhiza galabra exhibited significant and clear inhibition by about 60% at 40 mg/L (<xref ref-type="table" rid="table1">Table 1</xref>). In the following, therefore, our focus was on the effect of GA. Since the scatter of current measurements under voltage clamp to positive potentials in general is pretty large, we will concentrate on the analysis at negative potentials.</p></sec><sec id="s3_3"><title>3.3. GA Inhibits NCX<sub>1</sub>-Mediated Current</title><p>In the standard experiment, membrane currents were measured in different solutions with low Cl<sup>−</sup> and 100 nM niflumic acid that were applied usually in the sequence:</p><disp-formula id="scirp.74902-formula4"><graphic  xlink:href="http://html.scirp.org/file/10-2150320x6.png"  xlink:type="simple"/></disp-formula><p>The currents measured in the respective 0Ni<sup>2+</sup> solution before and after the</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Effect of selected drugs on Ni<sup>2+</sup>-sensitve current measured under voltage clamp at +10 mV. Data represent averages of N measurements (&#177;SEM). p values refer to difference to 1 (one-sample t-test)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Drug</th><th align="center" valign="middle" >Relative change in current at +10 mV</th><th align="center" valign="middle" >Significance p</th></tr></thead><tr><td align="center" valign="middle" >Ilex pubescens extract (40 mg/L)</td><td align="center" valign="middle" >0.83 &#177; 0.04 (N = 5)</td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle" >Gossampinusmalabrica extract (40 mg/L)</td><td align="center" valign="middle" >0.74 &#177; 0.05 (N = 4)</td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle" >Acorustatarinowii extract (40 mg/L)</td><td align="center" valign="middle" >1.15 &#177; 0.01 (N = 8)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >α-asarone (~40 mg/L ≈ 200 μM)</td><td align="center" valign="middle" >0.90 &#177; 0.03 (N = 4)</td><td align="center" valign="middle" >0.04</td></tr><tr><td align="center" valign="middle" >Glycyrrhic acid (GA) (~40 mg/L ≈ 85 &#181;M)</td><td align="center" valign="middle" >0.39 &#177; 0.13 (N = 5)</td><td align="center" valign="middle" >0.04</td></tr></tbody></table></table-wrap><p>application of 2 mM Ni<sup>2+</sup> were averaged to partially compensate for small drift with time. The currents in 2 mM Ni<sup>2+</sup> were then subtracted to obtain the NCX<sub>1</sub>- mediated current. In stable experiments, the <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/10-2150320x7.png" xlink:type="simple"/></inline-formula> sequence could be repeated with another drug concentration. In some experiments an abbreviated protocol was applied with the solution sequence</p><disp-formula id="scirp.74902-formula5"><graphic  xlink:href="http://html.scirp.org/file/10-2150320x8.png"  xlink:type="simple"/></disp-formula><p>The result of the effect of 20 μM GA on the current-voltage dependence of NCX-mediated current is illustrated in <xref ref-type="fig" rid="fig3">Figure 3</xref>(a) showing a significant inhibition of the activity of the exchanger over the entire potential range. A more detailed analysis of the concentration dependency yielded an IC<sub>50</sub> value of about 40 μM at −100 mV (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)). The inhibition did not significantly depend on membrane potential.</p></sec><sec id="s3_4"><title>3.4. The Effect of hCyPA on NCX-Mediated Current</title><p>Microinjection of hCyPA up to 86 ng/&#181;L (corresponding to 4.8 &#181;M within the cytoplasm, calculated by assuming an oocyte volume of 1 &#181;L) hardly affected the NCX<sub>1</sub>-mediated current (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)). Interestingly, extremely high concentration (9.6 &#181;M) obviously stimulated the current by about 30%. Despite the large error bars, the current increase is statistically significant.</p><p>Incubation of NCX<sub>1</sub>-expressing oocytes in 1.2 &#181;M hCyTA resulted in significant inhibition of NCX-mediated current (p &lt; 0.05 compared to untreated cells); higher concentration 4.8 &#181;M produced only insignificantly more inhibition (<xref ref-type="fig" rid="fig4">Figure 4</xref>(b)). Despite the considerable scatter of data an IC<sub>50</sub> value for 50% inhibition of less than 1 &#181;M could be estimated (see inset of <xref ref-type="fig" rid="fig4">Figure 4</xref>(b)). For the experiments described above, the oocytes were incubated in the respective hCyPA solution for 2 days. One hour of incubation already showed some tendency of inhibition (about 10%), but only after one day maximum inhibition could be detected. From 2 batches of oocytes we found that the current at −100 mV was after 1 h of incubation reduced to 0.87 &#177; 0.16 and after one day to 0.34 &#177;</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Inhibition of NCX-mediated current by GA. (a) Effect of 20 μM GA on current-voltage denendency. The data are normalised to the current at −60 mV in the absence of drug, and represent averages of N = 12 oocytes (&#177;SEM). (b) Dependence of NCX-medi- ated current at −100 mV on GA concentration. Data represent averages of N = 5 to 12 oocytes (&#177;SEM). The solid line is a fit of <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/10-2150320x10.png" xlink:type="simple"/></inline-formula> to the data with IC<sub>50</sub> = 40 μM (n = 0.5). I<sub>NCX</sub> is the normalised current at the respective drug concentration [GA]</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/10-2150320x9.png"/></fig><p>0.06 compared to untreated cells.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Asthma is a reversible airway restriction based on ASM contraction, which is governed by intracellular calcium. A key role plays the release of Ca<sup>2+</sup> from intracellular stores, and the refilling of the stores involves the reversed mode of NCX (for a brief review see [<xref ref-type="bibr" rid="scirp.74902-ref3">3</xref>] ). The aim of the present study was to examine effects of various drugs that inhibit the NCX, and hence might act as antiasthmatic drugs. We used Xenopus oocytes with heterologously expressed NCX<sub>1</sub> as a</p><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> The effect of hCyPA on NCX<sub>1</sub>-mediated current. (a) Effect of intracellular hCyPA. Oocytes injected with NCX<sub>1</sub>- cRNA were additionally microinjected with hCyPA to gain the respective intracellular concentration. Data represent averages of N = 5 to 11 oocytes &#177; SEM; (b) The effect of extracellular hCyPA. Oocytes were incubated in the respective amounts of hCyPA for two days. The inset shows the dependence of NCX<sub>1</sub>- mediated normalised current at −100 mV on hCyPA concentration. Data represent averages of N = 7 to 10 oocytes &#177; SEM. The inhibition of current at all concentrations is significant on the basis of p &lt; 0.05</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/10-2150320x11.png"/></fig><p>model system, and Ni<sup>2+</sup> as specific inhibitor of the exchanger. Effects on NCX<sub>1</sub>- mediated current could only be investigated as Ni<sup>2+</sup>-sensitive current in the presence of niflumic acid to block Ca<sup>2+</sup>-activated Cl<sup>−</sup>-currents and at lowered external Cl<sup>−</sup> activity. Otherwise the Ni<sup>2+</sup>-dependent current also included a large component of Ca<sup>2+</sup>-activated Cl<sup>−</sup> current (compare [<xref ref-type="bibr" rid="scirp.74902-ref27">27</xref>] ). Since the oocytes have functionally expressed only a limited number of endogenous membrane proteins, the application of this model system allows investigating effects on NCX with low background signals and restricted interference with other membrane proteins.</p><p>Our drug screening revealed that GA is a potent inhibitor of NCX<sub>1</sub>. GA has particularly been used in the treatment of liver diseases [<xref ref-type="bibr" rid="scirp.74902-ref5">5</xref>] , but also seems to have anti-asthmatic effects [<xref ref-type="bibr" rid="scirp.74902-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref7">7</xref>] . Since inhibition of NCX<sub>1</sub> in ASM will lead to reduced Ca<sup>2+</sup> influx and reduced refilling of the intracellular Ca<sup>2+</sup> stores, reduced muscle tone can be expected [<xref ref-type="bibr" rid="scirp.74902-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref4">4</xref>] . Though our measurements with GA were performed on the forward mode of NCX<sub>1</sub>, the screening experiments with effects on the outward-directed current at +10 mV indicate that also the reversed mode can be inhibited.</p><p>Several lines of evidence implicate that intracellular CyPA plays a critical multifunctional role, and interaction with cyclosporine A (CsA) has been shown to be an important step [<xref ref-type="bibr" rid="scirp.74902-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.74902-ref30">30</xref>] . Our functional analysis revealed that intracellular CyPA also affected the NCX<sub>1</sub> protein, and up-regulated NCX<sub>1</sub>-mediated current was observed though only at very high concentration of about 10 μM. The dissociation constant of CyPA from CsA is in the submicromolar range [<xref ref-type="bibr" rid="scirp.74902-ref31">31</xref>] . The much higher concentration in the micromolar range for intracellular stimulation of NCX<sub>1</sub> by CyPA, therefore, makes physiological relevance unlikely. On the other hand, Ca<sup>2+</sup> uptake experiments with HEK cells co-transfected with NCX<sub>1</sub> and CyPA suggest involvement of CyPA in the regulation of NCX<sub>1</sub> expression and transport activity [<xref ref-type="bibr" rid="scirp.74902-ref32">32</xref>] .</p><p>In fact CyPA can be secreted [<xref ref-type="bibr" rid="scirp.74902-ref16">16</xref>] via a vesicular pathway [<xref ref-type="bibr" rid="scirp.74902-ref14">14</xref>] . It had been demonstrated previously that acupuncture treatment on asthmatic rats can reduce airway restrictions [<xref ref-type="bibr" rid="scirp.74902-ref33">33</xref>] , and this was associated with the elevation of CyPA in the serum [<xref ref-type="bibr" rid="scirp.74902-ref10">10</xref>] . Our results suggest that extracellular hCyPA down-regulates NCX<sub>1</sub>-mediated current, which could account for release of the airway restrictions.</p><p>The involvement of extracellular CyPA in allergic lung inflammation had been suggested on the basis of the anti-inflammatory effect of an extracellularly applied membrane-impermeable CsA derivative [<xref ref-type="bibr" rid="scirp.74902-ref34">34</xref>] . Whether the effect of hCyPA found in our experiments results from direct interaction with the NCX protein needs further investigation. Our finding that the extracellular inhibition needed several hours of incubation is in favour of an indirect effect.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, our data suggest that GA and acupuncture-induced elevation of hCyPA in the serum may both contribute via inhibition of reversed NCX to reduced refilling of <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/10-2150320x12.png" xlink:type="simple"/></inline-formula> stores, which can promote reduced contraction of ASM, reduced airway restriction, and thus relieve the asthmatic symptoms. Such effects need to be verified in future animal experiments. Nevertheless, derivatives of GA and CyPA may form the basis for development of a new generation of more potent drugs for asthma therapy.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We are very grateful to Drs. Luis Beauge and Sheng Xu for providing the plasmids for NCX<sub>1</sub> and hCyPA, respectively, and to Drs. CG Huang, CH Ma, and LJ Xuan for the extracted herbal drugs. The excellent technical assistance from Heike Biehl, Guohui Chen, Huiming Du and Heike Fotis is gratefully acknowledged. This work was supported by the National Basic Research Development Program of China (No. 2012CB518502), Shanghai Key Laboratory of Acupuncture Mechanism and Acupoint Function (14DZ2260500), National Natural Science Funds of China (No. 30701123 to YW, No. 81403489 to YFX).</p></sec><sec id="s7"><title>Cite this paper</title><p>Laudenbach, J., Wang, Y., Xing, B.B., Schwarz, S., Xu, Y.F., Gu, Q.B. and Schwarz, W. (2017) Inhibition of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger NCX<sub>1</sub> Expressed in Xenopus Oocyte by Glycyrrhizic Acid and Cyclophylin A. Journal of Bio- sciences and Medicines, 5, 128-141. https://doi.org/10.4236/jbm.2017.53014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.74902-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Janssen, L.J. and Killian, K. (2006) Airway Smooth Muscle as a Target of Asthma Therapy: History and New Directions. Respiratory Research, 7, 123.  
https://doi.org/10.1186/1465-9921-7-123</mixed-citation></ref><ref id="scirp.74902-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Hirota, S., Pertens, E. and Janssen, L.J. (2007) The Reverse Mode of the Na+/Ca2+ Exchanger Provides a Source of Ca2+ for Store Refilling Agonist-Induced Ca2+ Mobilization. American Journal of Physiology Lung Cellular Molecular Physiology, 292, L438-L447. https://doi.org/10.1152/ajplung.00222.2006</mixed-citation></ref><ref id="scirp.74902-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Janssen, L.J. (2009) Asthma Therapy: How Far Have We Come, Why Did We Fail and Where Should We Go Next. European Respiratory Journal, 33, 11-20.  
https://doi.org/10.1183/09031936.00068508</mixed-citation></ref><ref id="scirp.74902-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hirota, S. and Janssen, L.J. (2007) Store-Refilling Involves Both L-Type Calcium Channels and Reverse-Mode Sodium-Calcium Exchange in Airway Smooth Muscle. European Respiratory Journal, 30, 269-278.  
https://doi.org/10.1183/09031936.00008507</mixed-citation></ref><ref id="scirp.74902-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Li, J.Y., Cao, H.Y., Liu, P., Cheng, G.H. and Sun, M.Y. (2014) Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review. Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review, 2014, Article ID: 872139.</mixed-citation></ref><ref id="scirp.74902-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ma, C., Ma, Z., Liao, X.L., Liu, J., Fu, Q. and Ma, S. (2013) Immunoregulatory Effects of Glycyrrhizic Acid Exerts Anti-Asthmatic Effects via Modulation of Th1/Th2 Cytokines and Enhancement of CD4(+) CD25(+) Foxp3+ Regulatory T Cells in Ovalbumin-Sensitized Mice. Journal of Ethnopharmacology, 148, 755-762.</mixed-citation></ref><ref id="scirp.74902-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ram, A., Mabalirajan, U., Das, M., Bhattacharya, I., Dinda, A.K., Gangal, S.V. and Ghosh, B. (2006) Glycyrrhizin Alleviates Experimental Allergic Asthma in Mice. International Immunopharmacology, 6, 1468-1477.</mixed-citation></ref><ref id="scirp.74902-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kao, T.C., Wu, C.H. and Yen, G.C. (2013) Glycyrrhizic Acid and 18a-Glycyrrhetinic Acid Recover Glucocorticoid Resistance via PI3K-Induced AP1, CRE and NFAT Activation. Phytomedicine, 20, 295-302.</mixed-citation></ref><ref id="scirp.74902-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wu, Q., Tang, Y., Hu, X., Wang, Q., Lei, W., Zhou, L. and Huang, J. (2016) Regulation of Th1/Th2 Balance through OX40/OX40L Signalling by Glycyrrhizic Acid in a Murine Model of Asthma. Respirology, 21, 102-111.  
https://doi.org/10.1111/resp.12655</mixed-citation></ref><ref id="scirp.74902-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Cui, J.M., Ma, S.L., Liu, Y.Y., Yin, L.M. and Yang, Y.Q. (2009) Proteomics Analysis of Component in Serum with Anti-Asthma Activity Derived from Rats Treated by Acupuncture. Journal of Acupuncture and Tuina Science, 7, 326-331. https://doi.org/10.1007/s11726-009-0326-y</mixed-citation></ref><ref id="scirp.74902-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">G&amp;ouml;thel, S.F. and Marahiel, M.A. (1999) Peptidy-Propyl Cis-Trans Isomerases, a Superfaliy of Ubiquitous Folding Catalysts. Cellular and Molecular Life Sciences, 55, 423-436. https://doi.org/10.1007/s000180050299</mixed-citation></ref><ref id="scirp.74902-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J., Farmer, J.D., Lane, W.S., Frieman, J. and Schreiber, S.L. (1991) Calcineurin Is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes. Cell, 66, 807-815.</mixed-citation></ref><ref id="scirp.74902-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bukrinsky</surname><given-names> M.I. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>Cyclophilins: Unexpected Messengers in Intercellular Communications</article-title><source> Trends in Immunology</source><volume> 23</volume>,<fpage> 323</fpage>-<lpage>324</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.74902-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, J., Jin, Z.G., Meoli, D.F., Matoba, T. and Berk, B.C. (2006) Cyclophilin A Is Secreted by a Vesicular Pathway in Vascular Smooth Muscle Cells. Circulation Research, 98, 811-817. https://doi.org/10.1161/01.RES.0000216405.85080.a6</mixed-citation></ref><ref id="scirp.74902-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Jin, Z.G., Lungu, A.O., Xie, L., Wang, M., Wong, C. and Berk, B.C. (2004) Cyclophilin A Is a Proinflammatory Cytokine That Activates Endothelial Cells. Arteriosclerosis Thrombosis and Vascular Biology, 24, 1186-1191.  
https://doi.org/10.1161/01.ATV.0000130664.51010.28</mixed-citation></ref><ref id="scirp.74902-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Jin, Z.G., Melaragno, M.G., Liao, D.F., Yan, C., Haendeler, J., Suh, Y.A., Lambeth, D. and Berk, B.C. (2000) Cyclophilin A Is a Secreted Growth Factor Induced by Oxidative Stress. Circulation Research, 87, 789-796.  
https://doi.org/10.1161/01.RES.87.9.789</mixed-citation></ref><ref id="scirp.74902-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Arora, K., Gwinn, W.M., Bower, M.A., Watson, A., Okwumabua, I., MacDonald, H.R., Bukrinsky, M.I. and Constant, S.L. (2005) Extracellular Cyclophilins Contribute to the Regulation of Inflammatory Responses. The Journal of Immunology, 175, 517-522. https://doi.org/10.4049/jimmunol.175.1.517</mixed-citation></ref><ref id="scirp.74902-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Wang, P. and Heitman, J. (2005) Protein Family Review: The Cyclophilins. Genome Biology, 6, 226. https://doi.org/10.1186/gb-2005-6-7-226</mixed-citation></ref><ref id="scirp.74902-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Dong, H., Dunn, J. and Lytton, J. (2002) Stoichiometry of the Cardiac Na+/Ca2+ Exchanger NCX1.1 Measured in Transfected HEK Cells. Biophysical Journal, 82, 1943-1952.</mixed-citation></ref><ref id="scirp.74902-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Bers, D.M. and Ginsburg, K.S. (2007) Na: Ca Stoichiometry and Cytosolic Ca-Dependent Activation of NCX in Intact Cardiomyocytes. Annals of the New York Academy of Sciences, 1099, 326-338. https://doi.org/10.1196/annals.1387.060</mixed-citation></ref><ref id="scirp.74902-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Luo, C., Luo, H., Zheng, S., Gui, C., Yue, L., Yu, C., Sun, T., He, P., Chen, J., Shen, J., Luo, X., Li, Y., Liu, H., Bai, D., Shen, J., Yang, Y., Li, F., Zuo, J., Hilgenfeld, R., Pei, G., Chen, K., Shen, X. and Jiang, H. (2004) Nucleocapsid Protein of SARS Corona Virus Tightly Binds to Human Cyclophilin A. Biochemical and Biophysical Research Communications, 321, 557-565.</mixed-citation></ref><ref id="scirp.74902-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Z., Mi, L., Xu, J., Yu, J., Wang, X., Jiang, J., Xing, J., Shang, P., Qian, A., Li, Y., Shaw, P.X., Wang, J., Duan, S., Ding, J., Fan, C., Zhang, Y., Yang, Y., Yu, X., Feng, Q., Li, B., Yao, X, Zhang, Z., Xue, X. and Zhu, P. (2005) Function of HAb18G/CD 147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus. The Journal of Infectious Diseases, 191, 755-760. https://doi.org/10.1086/427811</mixed-citation></ref><ref id="scirp.74902-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Dumont, J.N. (1972) Oogenesis in Xenopus Laevis (Daudin): I. Stages of Oocyte Development in Laboratory Maintained Animals. Journal of Morphology, 136, 153-180. https://doi.org/10.1002/jmor.1051360203</mixed-citation></ref><ref id="scirp.74902-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Rakowski, R.F., Vasilets, L.A., LaTona, J. and Schwarz, W. (1991) A Negative Slope in the Current-Voltage Relationship of the Na+/K+ Pump in Xenopus Oocytes Produced by Reduction of External [K+]. The Journal of Membrane Biology, 121, 177-187. https://doi.org/10.1007/BF01870531</mixed-citation></ref><ref id="scirp.74902-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Dipolo, R. and Beauge, L. (2006) Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions. Physiological Reviews, 86, 155-203.  
https://doi.org/10.1152/physrev.00018.2005</mixed-citation></ref><ref id="scirp.74902-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Supplisson, S., Kado, R.T. and Bergman, C. (1991) A Possible Na/Ca Exchange in the Follicle Cells of Xenopus Oocyte. Developmental Biology, 145, 231-240.</mixed-citation></ref><ref id="scirp.74902-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Ruknudin, A., He, S., Lederer, W.J. and Schulze, D.H. (2000) Functional Differences between Cardiac and Renal Isoforms of the Rat Na+-Ca2+ Exchanger NCX1 Expressed in Xenopus Oocytes. The Journal of Physiology, 529, 599-610.  
https://doi.org/10.1111/j.1469-7793.2000.00599.x</mixed-citation></ref><ref id="scirp.74902-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weber</surname><given-names> W.M. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Ion Currents of Xenopus Laevis Oocytes: State of the Art</article-title><source> Biochimica et Biophysica Acta</source><volume> 1421</volume>,<fpage> 213</fpage>-<lpage>233</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.74902-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">White, M.M. and Aylwin, M. (1990) Niflumic and Flufenamic Acids Are Potent Reversible Blockers of Ca-2+-Activated Cl-Channels in Xenopus Oocytes. Molecular Pharmacology, 37, 720-724.</mixed-citation></ref><ref id="scirp.74902-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Satoh, K., Shimokawa, H. and Berk, B.C. (2010) Cyclophilin A—Promising New Target in Cardiovascular Therapy .Circulation Journal, 74, 2249-2256.</mixed-citation></ref><ref id="scirp.74902-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Handschumacher, R.E., Harding, M.W., Rice, J., Drugge, R.J. and Speicher, D.W. (1984) Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A. Science, 226, 544-547. https://doi.org/10.1126/science.6238408</mixed-citation></ref><ref id="scirp.74902-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Rahamimoff, H., Elbaz, B., Kimchi-Sarfaty, C., Gottesman, M.M., Lichtenstein, Y., Eskin-Shwartz, M. and Kasir, J. (2007) Cyclosporin A-Dependent Downregulation of the Na+/Ca2+ Exchanger Expression. Annals of the New York Academy of Sciences, 1099, 204-214. https://doi.org/10.1196/annals.1387.046</mixed-citation></ref><ref id="scirp.74902-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Xu, Y.D., Cui, J.M., Wang, Y., Yin, L.M., Gao, C.K., Liu, Y.Y. and Yang, Y.Q. (2010) The Early Asthmatic Response Is Associated with Glycolysis, Calcium Binding and Mitochondria Activity as Revealed by Proteomic Analysis in Rats. Respiratory Research, 11, 107. https://doi.org/10.1186/1465-9921-11-107</mixed-citation></ref><ref id="scirp.74902-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Balsley, M.A., Malesivic, M., Stemmy, E.J., Gigley, J., Jurjus, R.A., Herzog, D., Bukrinsky, M.I., Fischer, G. and Constant, S. (2010) A Cell-Impermeable Cylosporin a Derivative Reduces Pathology in a Mouse Model of Allergic Lung Inflammation. The Journal of Immunology, 185, 7663-7670.  
https://doi.org/10.4049/jimmunol.1001707</mixed-citation></ref></ref-list></back></article>